A comprehensive systematic review and meta-analysis published in the Journal of the American Academy of Child & Adolescent Psychiatry found no association between prenatal acetaminophen exposure and the risk of neurodevelopmental disorders, including autism and ADHD. The study offers reassurance for pregnant women, public health agenci...
SourceElsevier·JournalJournal of the American Academy of Child & Adolescent Psychiatry·TypeSystematic review·DateNov 6, 2025
A large global study of 23,000 people found that proton pump inhibitors (PPIs) used for indigestion and heartburn were associated with poorer overall survival and a higher risk of severe side effects in patients with breast cancer. Statins and metformin showed no significant impact on either survival or adverse events.
West Virginia University researchers are working with local partners to stop drug use in youth before it starts. They will expand an existing pilot project to encompass 140 schools in 36 rural counties, tailored to individual community needs.
A new drug-eluting balloon has been shown to match the outcomes of standard care for in-stent restenosis, offering a safer alternative for patients with multiple stent layers. The study's results suggest that patients with complex or multilayer ISR may benefit from sirolimus-eluting balloons as a viable treatment option.
A study found that first-generation antihistamines may increase delirium risk in older hospital patients. The analysis of 328,140 patients aged 65+ revealed a 41% increased odds of delirium among those prescribed higher amounts of these medications.
Research reveals an increase in emergency calls for pediatric opioid exposure among middle-school aged children, with a national trend of rising calls from 255 in 2019 to 553 in 2023. Teenagers showed a decline after 2022. Demographics varied by age group, with females outnumbering males in the middle school age group.
A new study found that Australian women of reproductive age taking GLP-1 receptor agonists are not using effective contraception, despite known risks during pregnancy. The research revealed a higher risk of pregnancy among younger women with diabetes and those without diabetes in their early thirties.
A new class of targeted therapy showed promise in treating head and neck squamous cell carcinoma (HNSCC) in pet cats, with 35% of patients experiencing controlled disease. The drug, which targets the transcription factor STAT3, also raised levels of PD-1, a protein associated with an immune response to cancer.
A new study finds that up to 18% of women are advised to stop breastfeeding due to medication, while chronic illness increases this number to 58%. The research highlights the need for accurate and balanced information about medication safety during breastfeeding.
Researchers detected traces of nitazene in discarded injecting equipment and syringes in Adelaide, Australia. Nitazenes led to 32 overdose deaths with 84% of patients unaware of the synthetic opioid's presence.
Researchers validated panels of antibodies targeting clinically relevant nucleic acid modifications to visualize antisense oligonucleotides in both in vitro and in vivo studies. The tools enable detection of modified nucleic acids irrespective of sequence, facilitating multiple clinical and pre-clinical workflows.
A study of over 2,500 adults aged 50-80 found that nearly 1 in 6 take aspirin for cardiovascular protection without a history of heart disease. Despite revised guidelines reducing aspirin use for primary prevention after age 70, many patients are unaware of the increased risk of bleeding.
A new study from the University of Bath found that inappropriate polypharmacy is a major driver of emergency hospital admissions among adults aged 65 and over. The researchers developed a digital tool to proactively identify older adults at risk of medication-related harm, which could reduce preventable emergency hospitalisations.
A study published in The Lancet Global Health found serious quality defects in a significant number of cancer medications from sub-Saharan Africa. Researchers evaluated 251 samples and discovered that one in six medications contained the incorrect quantity of active pharmaceutical ingredient, posing patient safety risks.
Microscopic colitis is a chronic inflammatory condition characterized by watery diarrhea and distinctive histologic features. The two primary subtypes are collagenous colitis and lymphocytic colitis, with collagenous colitis showing a stronger female predominance.
Researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine aim to reduce falls and adverse drug events among older adults by using personalized approach tailored to individual genetic profiles.
The UT Health San Antonio Multispecialty and Research Hospital is the first in Texas to approve use of suzetrigine, a new non-opioid medication for post-surgical pain. This medication targets the peripheral nervous system, avoiding opioid-related side effects.
A new book by Professor Aldrin Gomes details the benefits and risks of ibuprofen, including its interaction with over 400 prescription drugs and impact on cardiovascular health. The comprehensive guide aims to educate readers about responsible painkiller use and natural alternatives.
Researchers developed a technique to separate and quantify ions, nanoparticles, and aggregates in nanomedicines, improving quality control for advanced pharmaceutical products. This method ensures the safe use of metal-based nanomedicines by distinguishing between their different forms.
Research reveals individuals taking oral steroids for over 3 months are 6 times more likely to be diagnosed with adrenal insufficiency than those treated with non-steroidal anti-inflammatory drugs. Long-term users of inhaled steroids also face increased risk without hospitalisations.
Research suggests that antibiotics taken during infancy, especially in the first three months, may lead to earlier onset of puberty in girls. The study, which analyzed data on over 322,000 children in South Korea, found a significant association between early antibiotic exposure and increased risk of central precocious puberty.
The Swiss Memory Clinics network has released new national guidelines on the use of anti-amyloid monoclonal antibodies, such as Lecanemab and Donanemab, for treating Alzheimer's disease. The guidelines outline criteria for patient selection, biomarker confirmation, and infrastructure requirements to support safe treatment delivery.
A new study in The Lancet Public Health finds that safer supply programs complement existing treatment options for people struggling with opioid use disorder. Safer supply programs provide pharmaceutical-grade opioids to reduce overdose rates, healthcare utilization, and costs.
Common prescription medications can disrupt sterol biosynthesis, potentially causing developmental disorders. The editorial highlights the need for mandatory sterol biosynthesis screening in clinical practice.
A multisource observational study found psilocybin use increased across all age groups, with those having mental or physical comorbidities being the most common users. Psilocybin exposure rates reported to U.S. poison centers increased significantly among adults and children.
A study found that psilocybin use increased nationwide since 2019, particularly among young adults and older adults with conditions like depression and anxiety. The researchers urge better education, tracking, and health system preparedness as poison center calls rise.
A recent study published in Current Neuropharmacology suggests a potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists and depression, particularly in individuals with low dopamine function. The authors urge caution and recommend genetic testing to identify individuals at risk before prescribing these medications.
A study published by the European Association for the Study of Obesity found that women are significantly more aware of and have a better understanding of obesity drugs like semaglutide and tirzepatide. Understanding tolerable side effects, effectiveness, and ability to maintain weight loss is crucial for people commencing treatment.
University of Virginia researcher Natasha D. Sheybani has received a $5.5 million grant to advance her research on focused ultrasound technology for breast cancer immunotherapy. Her work aims to enhance the safety, effectiveness, and precision of immunotherapy drugs.
Novel biomarkers like miRNA-34a link anthracyclines to cardiotoxicity, while stem cell therapy and nanotechnology offer potential for prevention and treatment. Traditional strategies have limitations, but new approaches hold hope for improved patient outcomes.
A team of scientists at the University of Florida has developed a new drug compound that selectively targets delta opioid receptors, providing pain relief without the dangerous side effects associated with opioids. The study's findings offer a promising approach to developing safer pain treatments, which could also be applied to treati...
A Rice University-led team developed an implantable 'cytokine factory' that triggers potent immune responses against hard-to-treat cancers. The IL-12 cytokine factory successfully induces the recruitment of tumor-targeting T cells, eliminating local and distal tumors in preclinical models.
The expansion of mifepristone to community pharmacies has increased access to abortion services in Ontario, with the proportion of regions with a pharmacy or procedural provider growing from 20% to 82%. The study found that access to abortion services improved in both urban and rural areas.
A new analysis suggests that fees for food companies could generate much-needed resources for the FDA to strengthen its oversight of foods and keep unsafe ingredients out of the market. The FDA's current lack of resources hampers its ability to ensure the safety of the country's food supply, with growing concerns about the agency's ina...
A new study published in The Lancet Psychiatry found that ADHD medications have small but significant effects on blood pressure and heart rate. While there were concerns about the side effects of these medications, the study suggests that their benefits outweigh the risks.
In an open-label study, patients hospitalized for a serious heart attack who received rivaroxaban or warfarin had similar efficacy and safety outcomes. Rivaroxaban showed comparable results in dissolving left ventricular blood clots at three months follow-up.
Researchers propose GLDH as a more liver-specific biomarker for detecting liver injury, offering greater specificity than current ALT and AST tests. The test performed similarly to ALT for detecting liver injury but was not impacted by associated muscle injury.
Researchers have identified six promising biomarkers that can detect drug-induced kidney injury earlier than traditional markers, enabling more timely monitoring during drug development. These biomarkers could lead to the development of safer medications and improve patient outcomes.
A UniSA-led study is trialing medication safety rounds in aged care homes to identify and address potential problems with medication use. The project aims to reduce medication-induced harm and improve residents' health and wellbeing through pharmacist-led safety rounds, adapting an existing palliative care need rounds model.
A study found that genetic variants in three genes (CYP2C19, CYP2D6, SLCO1B1) can lead to adverse reactions in up to 75% of cases. This could allow for personalized prescribing and reduce ADRs by three quarters.
The Ochsner Children's & ISMP Safe Medication Management Fellowship aims to educate pharmacist leaders in the fight against medication errors. Participants will learn from ISMP's experts virtually and support error prevention efforts onsite at Ochsner Children's in New Orleans.
The Dexcom G7 CGM device demonstrated an accuracy of 8.0% in a study involving 130 adults with type 1 or type 2 diabetes, setting a new standard for continuous glucose monitoring devices.
More than 20 leading organizations and providers urge the FDA to take action following the recent resolution of GLP-1 medicine shortages. Signatories include the Alliance for Women’s Health & Prevention, Association of Black Cardiologists, and National Hispanic Medical Association.
Researchers have confirmed the presence of xylazine in Tijuana's illicit drug supply, posing severe health risks due to sedation, withdrawal syndromes, skin infections, and wounds. The study highlights the need for public health intervention and expanded surveillance to mitigate the spread of xylazine in the region.
A study from Aarhus University found a possible link between JAK inhibitor medication and unexpected blood clots. The researchers identified a potential mechanism behind the side effect, which could lead to the development of safer medications.
The UMass Amherst nurse-engineer team, led by Elaine Marieb Center for Nursing and Engineering Innovation, has developed an innovative IV pole designed to enhance patient safety and reduce errors. The award-winning design features a smart pump that can detect potential problems and alert medical staff, improving overall care.
The Study of Tecovirimat for Mpox (STOMP) trial found that tecovirimat did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control. The antiviral drug was shown to be safe but ineffective in treating clade II mpox.
Fentanyl poisoning among US children has surged by 924% and 1,506% for teens aged 13-19 over the past eight years. Parents are advised to be vigilant about hidden fentanyl risks and know the signs of overdose symptoms to save their children.
Eradivir's EV25 is a small molecule immunotherapy biotech company developing treatments for influenza. The Phase 2 challenge study will gather safety and efficacy data from healthy participants infected with influenza.
A new study from Texas A&M University's Mosbacher Institute found that reducing violent crime in El Salvador significantly decreased Central American emigration to the US. Homicide rates dropped by 87% after President Nayib Bukele implemented a crackdown, resulting in a 45-67% reduction in border apprehensions.
A new stem cell transplant treatment has shown promising results in clearing clinical safety hurdles for the treatment of wet age-related macular degeneration. The treatment involves removing abnormal blood vessels and transplanting stem cell-derived retinal cells to replace damaged or lost retinal cells.
The FDA has resolved Novo Nordisk's Wegovy and Ozempic shortages, ensuring access to critical medications for obesity and diabetes treatment. The Obesity Society urges the FDA to enforce regulations against unauthorized GLP-1 compounders, highlighting concerns over safety and efficacy.
A new study found that nearly 20% of cancer patients in middle-stage drug trials receive treatment that later gets FDA approval. This has important implications for drug development and clinical trial recruitment.
Researchers have discovered that commonly prescribed medications can disrupt sterol biosynthesis in developing brains, potentially affecting neural development and function. The study highlights the need for reevaluating medication safety during pregnancy and early childhood.
Professor Collen Masimirembwa receives Precision Medicine World Conference Pioneer Award for his groundbreaking work in pharmacogenomics, advancing personalised medicine and tailoring treatments to individual genetic profiles. His research has improved patient outcomes and saved lives by uncovering critical issues with HIV medications.
A global study by Amsterdam UMC found that new medication direct oral anticoagulants (DOACs) are equally safe and effective as vitamin K antagonists (VKAs) for treating sinus thrombosis. Regular monitoring is no longer necessary, making it more user-friendly.
A study by University of Bath researchers found that stopping anticoagulants for patients aged 75 and over does not significantly affect the risk of major bleeding, but increases the risk of serious events like stroke and death. This highlights the need for clinicians to carefully consider the risks of stopping anticoagulation therapy ...
A University of Cincinnati researcher has been awarded a $2.1 million grant to investigate postoperative pain at the molecular and cellular levels. The goal is to develop new, safer non-addictive treatments for chronic pain conditions, including lower back pain and pain associated with diabetes or chemotherapy treatments.
A new clinical trial will evaluate whether adding ketamine to standard treatment can improve outcomes for patients suffering from status epilepticus. The trial, called KESETT, hopes to determine whether ketamine can terminate the seizures in more patients than current treatments.
New cyanine-carborane salts show promise in eradicating metastatic breast cancer tumors with minimal side effects. The therapy targets specific proteins in cancer cells, allowing for precise killing of diseased cells while sparing healthy tissue.